Medical Foods and Dietary Supplements

Representative experience

Represented dietary supplement companies in successfully responding to FTC inquiries on nutrition-related claims, resulting in closure of the investigations or consent orders to resolve threatened enforcement.

Assisted clients in developing health claim petitions that would authorize the use of various health claims on dietary supplements and conventional foods.

Successfully represented several importers of dietary supplements and other products in obtaining release of FDA-detained shipments, enabling the importation of commodities and minimizing marketing disruptions.

Conducted due diligence investigations for companies subject to takeover or merger activity, assisting with identifying serious regulatory deficiencies to stop a company from acquiring another’s problems.

For dietary supplement companies planning to undertake clinical research, we are providing counsel as to whether Investigational New Drug (IND) applications are required or prudent.

Counseled dietary supplement and other companies on product classification issues and the regulatory pathway (e.g., food, dietary supplement, medical food, drug) most likely to meet desired objectives.

Helped clients assess the status of proposed claims and ingredients (especially new dietary ingredients) and prepare any necessary notifications to the FDA.

A Seat at the Table

Our food law and policy blog helps you stay up to date on the developments in the food, beverage, and agriculture industry.

Sponsorships and Speaking Engagements

Medical Foods Workshop: Science, Regulation and Practical Aspects

14 August 2019

Xin Tao will serve as a panelist during the "Concepts around Differentiating Medical Foods and FSDU" session on 14 August.

Hogan Lovells Publications

Regulation of cannabis in Italy: Use in food and cosmetics

31 July 2019

In Italy the cultivation and the industrial use of hemp has a long tradition and recent changes in law have led to a revival.

Hogan Lovells Publications

Dietary Supplement Regulation Update: FDA Announces Public Meeting on Responsible Dietary Supplement Innovation; FDA Launches Dietary Supplement Ingredient Advisory List

23 April 2019

As a part of the Food and Drug Administration’s (FDA’s) initiative to modernize and reform dietary supplement oversight, FDA announced it will hold a public meeting on...

Hogan Lovells Publications